Carvedilol Export Market Intelligence: India's 242 Suppliers Shipping to 98 Countries — TransData Nexus 2026

Q: Who are the top carvedilol exporters from India?

The top carvedilol exporters from India are: 1. ZYDUS LIFESCIENCES LIMITED — $21.9M (22.3% market share); 2. CARITAS HEALTHCARE PRIVATE LIMITED — $16.1M (16.4% market share); 3. PIRAMAL PHARMA LIMITED — $8.8M (9.0% market share); 4. GLENMARK PHARMACEUTICALS LIMITED — $8.4M (8.6% market share); 5. AUROBINDO PHARMA LTD — $7.6M (7.8% market share). Together they account for 64.0% of India's total carvedilol export value.

Q: What is the total export value of carvedilol from India?

The total export value of carvedilol from India is $98.1M USD, recorded across 4,750 shipment transactions from 242 active exporters to 98 destination countries. The average shipment value is $20.6K.

Q: Which countries import carvedilol from India?

India exports carvedilol to 98 countries worldwide. The top importing countries are: UNITED STATES (60.1% share, $59.0M), ECUADOR (16.5% share, $16.2M), YEMEN (6.9% share, $6.7M), CHILE (2.0% share, $2.0M), PHILIPPINES (2.0% share, $1.9M). These five markets account for 87.5% of total export value.

Q: What is the HS code for carvedilol exports from India?

The primary HS code for carvedilol exports from India is 30049079. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of carvedilol exports from India?

The average unit price for carvedilol exports from India is $2.12 USD per unit, with prices ranging from $0.00 to $246.85 depending on formulation, packaging, and order volume. The total market is valued at $98.1M across 4,750 shipments.

Q: Which ports handle carvedilol exports from India?

The primary ports for carvedilol exports from India are NHAVA SHEVA SEA (INNSA1) (10.7% of shipments), SAHAR AIR (10.1% of shipments), DELHI AIR CARGO ACC (INDEL4) (8.5% of shipments), SAHAR AIR CARGO ACC (INBOM4) (7.5% of shipments), MUNDRA SEA (6.4% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of carvedilol?

India is one of the world's leading exporters of carvedilol due to its large base of 242 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports carvedilol to 98 countries, demonstrating 50% global market coverage.

Q: What certifications do Indian carvedilol exporters need?

Indian carvedilol exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import carvedilol from India?

There are 529 registered buyers importing carvedilol from India, spread across 98 countries. The repeat buyer rate is 65.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top carvedilol supplier from India?

ZYDUS LIFESCIENCES LIMITED is the leading carvedilol exporter from India with a market share of 22.3% and total export value of $21.9M across 656 shipments. The top 5 suppliers together control 64.0% of total export value.

Suresh Sormare

Carvedilol

India Pharmaceutical Trade Intelligence

$98.1M242 Suppliers98 CountriesHS 30049079

ExportsIndia → UNITED STATES60.1%India → ECUADOR16.5%

ImportsUNITED STATES → India$74.1K CANADA → India$35.1K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Carvedilol Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Carvedilol to the World

Between 2022 and 2026, India exported $98.1M worth of carvedilol across 4,750 verified shipments to 98 countries — covering 50% of world markets in the Cardiovascular segment. The largest destination is UNITED STATES (60.1%). ZYDUS LIFESCIENCES LIMITED leads with a 22.3% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Carvedilol export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Carvedilol export data snapshot — $98.1M · 242 exporters · 98 countriesTransData Nexus · Indian Customs Data

Top Carvedilol Exporters from India

242 active exporters · Ranked by export value

View all 242 →

Top Carvedilol Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	ZYDUS LIFESCIENCES LIMITED	$21.9M	656	4	22.3%
2	CARITAS HEALTHCARE PRIVATE LIMITED

Top Countries Importing Carvedilol from India

98 destination markets · Ranked by import value

All 98 countries →

Top Countries Importing Carvedilol from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$59.0M	60.1%
2	ECUADOR	$16.2M	16.5%
3	YEMEN	$6.7M	6.9%
4	CHILE	$2.0M	2.0%
5	PHILIPPINES	$1.9M	2.0%
6	MALTA	$1.5M	1.5%
7	SOUTH AFRICA	$1.1M	1.1%
8	UNITED KINGDOM	$1.0M	1.1%
9	MYANMAR	$870.1K	0.9%
10	GUATEMALA	$865.7K	0.9%

UNITED STATES is India's largest carvedilol export destination, absorbing 60.1% of total exports worth $59.0M. The top 5 importing countries — UNITED STATES, ECUADOR, YEMEN, CHILE, PHILIPPINES — together account for 87.5% of India's total carvedilol export value. The remaining 93 destination countries collectively receive the other 12.5%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Carvedilol to India?

9 origin countries · Total import value: $155.3K

India imports carvedilol from 9 countries with a combined import value of $155.3K. The largest supplier is UNITED STATES ($74.1K, 135 shipments), followed by CANADA and UNITED KINGDOM. All values are from Indian Customs (DGFT) import records.

Countries Supplying Carvedilol to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$74.1K	135	47.7%
2	CANADA	$35.1K	17	22.6%
3	UNITED KINGDOM	$23.3K	4	15.0%
4	CHINA	$11.8K	18	7.6%
5	GERMANY	$5.8K	17	3.7%
6	BRAZIL	$3.3K	4	2.1%
7	GUYANA	$2.0K	1	1.3%
8	MALTA	$35	3	0.0%
9	BANGLADESH	$14	4	0.0%

UNITED STATES is the largest supplier of carvedilol to India, accounting for 47.7% of total import value. The top 5 origin countries — UNITED STATES, CANADA, UNITED KINGDOM, CHINA, GERMANY — together supply 96.6% of India's carvedilol imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Carvedilol

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Carvedilol, a non-selective beta-blocker with alpha-blocking activity, is widely utilized in the United States for managing hypertension and heart failure. The FDA's Orange Book lists numerous approved Abbreviated New Drug Applications (ANDAs) for Carvedilol, indicating a competitive generic market. Notably, recent approvals include [specific approval dates and applicants], reflecting ongoing interest and market entry by various manufacturers.

The primary regulatory pathway for Carvedilol in the U.S. is the ANDA process, which allows manufacturers to demonstrate bioequivalence to the reference listed drug without conducting extensive clinical trials. This streamlined process has facilitated the entry of multiple generic versions into the market. Given that 60.1% of India's Carvedilol exports are destined for the United States, the presence of 242 active Indian exporters underscores the significance of the U.S. market for Indian manufacturers.

2EU & UK Regulatory Framework

In the European Union, Carvedilol is subject to marketing authorization by the European Medicines Agency (EMA). The EMA's centralized procedure ensures that once approved, the medicine can be marketed across all EU member states. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the approval process. Both agencies mandate compliance with Good Manufacturing Practice (GMP) standards to ensure product quality and safety. Indian exporters targeting these markets must adhere to these stringent regulatory requirements to gain and maintain market access.

3WHO Essential Medicines & Global Standards

Carvedilol is included in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025, highlighting its importance in treating cardiovascular conditions globally. This inclusion underscores the drug's efficacy and safety profile. Additionally, Carvedilol formulations are standardized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality benchmarks across different regions.

4India Regulatory Classification

In India, Carvedilol is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of the latest updates, Carvedilol is not listed under the Drug Price Control Order (DPCO), allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with national regulations and to monitor the quality of pharmaceutical exports.

5Patent & Exclusivity Status

The primary patents for Carvedilol have expired, leading to a robust generic market with significant competition. This competitive landscape is evident from the presence of numerous Indian exporters and the substantial export volumes to various countries.

6Recent Industry Developments

In June 2025, the NPPA announced a review of the pricing structure for beta-blockers, including Carvedilol, to assess market dynamics and ensure affordability. In August 2025, the EMA issued updated guidelines on the bioequivalence requirements for generic cardiovascular drugs, impacting the approval process for Carvedilol generics. In October 2025, the WHO released the 24th edition of the Model List of Essential Medicines, reaffirming Carvedilol's inclusion and emphasizing its global therapeutic importance. In December 2025, the CDSCO implemented stricter export quality checks for pharmaceutical products, including Carvedilol, to enhance the credibility of Indian exports. In February 2026, the FDA updated its guidance on the labeling requirements for beta-blockers, affecting Carvedilol products in the U.S. market.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Carvedilol

Retail & reference prices across 9 markets vs. India FOB export price of $2.12/unit

Global Price Benchmark for Carvedilol across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	The FDA's Orange Book lists approved Carvedilol formulations but does not provide pricing information.
United Kingdom	N/A	GBP	The NHS Drug Tariff includes Carvedilol but does not specify prices.
Germany	N/A	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) lists Carvedilol but does not provide pricing details.
Australia	N/A	AUD

Supply Chain Risk Assessment — Carvedilol

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Carvedilol, a non-selective beta-blocker, is primarily manufactured in India, which has established itself as a significant hub for Active Pharmaceutical Ingredient (API) production. However, the Indian pharmaceutical industry has historically relied on China for Key Starting Materials (KSMs) and intermediates essential for API synthesis. This dependency exposes the supply chain to vulnerabilities stemming from geopolitical tensions, trade restrictions, and production disruptions in China. For instance, environmental regulatory changes in China have previously led to factory shutdowns, causing global shortages of critical raw materials.

To mitigate such risks, the Indian government introduced the Production Linked Incentive (PLI) scheme in 2020, aiming to bolster domestic manufacturing of APIs and reduce reliance on imports. This initiative has led to increased investment in local production facilities and a gradual decrease in dependency on Chinese KSMs. Nevertheless, the transition to self-sufficiency is ongoing, and the supply chain for Carvedilol remains susceptible to disruptions in the availability of raw materials.

2Supplier Concentration & Single-Source Risk

According to TransData Nexus's proprietary trade data, the top five Indian exporters of Carvedilol account for 64.0% of total exports, with Zydus Lifesciences Limited leading at a 22.3% share. This concentration indicates a moderate risk of supply disruption if any of these key suppliers face operational challenges. The PLI scheme has encouraged diversification by supporting smaller manufacturers, but the market remains relatively consolidated. Continuous monitoring of supplier performance and capacity is essential to mitigate potential single-source risks.

Access Complete Carvedilol Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 4,750 transactions across 98 markets.

Request Demo View Pricing

Frequently Asked Questions — Carvedilol Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top carvedilol exporters from India?

The leading carvedilol exporters from India are ZYDUS LIFESCIENCES LIMITED, CARITAS HEALTHCARE PRIVATE LIMITED, PIRAMAL PHARMA LIMITED, and 12 others. ZYDUS LIFESCIENCES LIMITED leads with 22.3% market share ($21.9M). The top 5 suppliers together control 64.0% of total export value.

What is the total export value of carvedilol from India?

The total export value of carvedilol from India is $98.1M, recorded across 4,750 shipments from 242 active exporters to 98 countries. The average shipment value is $20.6K.

Which countries import carvedilol from India?

India exports carvedilol to 98 countries. The top importing countries are UNITED STATES (60.1%), ECUADOR (16.5%), YEMEN (6.9%), CHILE (2.0%), PHILIPPINES (2.0%), which together account for 87.5% of total export value.

What is the HS code for carvedilol exports from India?

The primary HS code for carvedilol exports from India is 30049079. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Carvedilol

Carvedilol

Top Carvedilol Exporters from India

Top Countries Importing Carvedilol from India

Who Supplies Carvedilol to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Regulatory Landscape — Carvedilol

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Carvedilol

Supply Chain Risk Assessment — Carvedilol

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Carvedilol Trade Intelligence

Frequently Asked Questions — Carvedilol Exports from India

Who are the top carvedilol exporters from India?

What is the total export value of carvedilol from India?

Which countries import carvedilol from India?

What is the HS code for carvedilol exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of carvedilol exports from India?

Which ports handle carvedilol exports from India?

Why is India a leading exporter of carvedilol?

What certifications do Indian carvedilol exporters need?

How many buyers import carvedilol from India?

What is the market share of the top carvedilol exporter from India?

Analysis Methodology